T1	PROC 45 55	VACUNACIÓN
#1	AnnotatorNotes T1	C0042196; Vaccination; Therapeutic or Preventive Procedure
T2	DISO 74 85	HEPATITIS B
#2	AnnotatorNotes T2	C0019163; Hepatitis B; Disease or Syndrome
T3	PROC 623 644	títulos de Ac antiHBs
T4	PROC 272 281	vacunados
#3	AnnotatorNotes T4	C0042196; Vaccination; Therapeutic or Preventive Procedure
T5	PROC 309 319	vacunación
#4	AnnotatorNotes T5	C0042196; Vaccination; Therapeutic or Preventive Procedure
T6	DISO 343 354	Hepatitis B
#5	AnnotatorNotes T6	C0019163; Hepatitis B; Disease or Syndrome
T7	PROC 775 799	consentimiento informado
#6	AnnotatorNotes T7	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T8	DISO 610 621	hepatitis B
#7	AnnotatorNotes T8	C0019163; Hepatitis B; Disease or Syndrome
T9	PROC 665 675	aplicación
#8	AnnotatorNotes T9	C0185125; Application procedure; Therapeutic or Preventive Procedure
T10	PROC 735 741	pautas
#9	AnnotatorNotes T10	C0935576; treatment guideline; Therapeutic or Preventive Procedure
T11	DISO 825 832	Alergia
#10	AnnotatorNotes T11	C1527304; Allergic Reaction; Pathologic Function
T12	CHEM 906 917	medicamento
#11	AnnotatorNotes T12	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T13	DISO 1009 1026	reacción alérgica
#12	AnnotatorNotes T13	C1527304; Allergic Reaction; Pathologic Function
T14	DISO 1058 1069	hepatitis B
#13	AnnotatorNotes T14	C0019163; Hepatitis B; Disease or Syndrome
T15	DISO 1083 1092	infección
#14	AnnotatorNotes T15	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T16	DISO 1103 1109	fiebre
#15	AnnotatorNotes T16	C0015967; Fever; Sign or Symptom
T17	CHEM 146 152	VACUNA
#16	AnnotatorNotes T17	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T18	CHEM 845 861	principio activo
#17	AnnotatorNotes T18	C1372955; Active ingredient; Chemical Viewed Functionally
T19	CHEM 585 591;605 621	vacuna para hepatitis B
#18	AnnotatorNotes T19	C2240392; Hepatitis B Vaccines; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T20	CHEM 634 644	Ac antiHBs
T21	CHEM 693 699	vacuna
#19	AnnotatorNotes T21	C0042210; Vaccines; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T22	CHEM 1039 1069	vacuna frente a la hepatitis B
T23	PROC 1150 1174	consentimiento informado
#20	AnnotatorNotes T23	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T24	PROC 1208 1222	consentimiento
#21	AnnotatorNotes T24	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T25	Date 13 17	2016
T27	LIVB 187 220	Trabajadores del ámbito sanitario
#22	AnnotatorNotes T27	C1704312; Health professional; Professional or Occupational Group
T31	Dose 679 689	seis dosis
T32	Dose 724 729	20 μg
T33	LIVB 753 760	Sujetos
#23	AnnotatorNotes T33	C0681850; Study Subject; Group
T36	LIVB 1111 1118	Sujetos
#24	AnnotatorNotes T36	C0681850; Study Subject; Group
T37	Neg_cue 1133 1135	no
T38	LIVB 1175 1182	Sujetos
#25	AnnotatorNotes T38	C0681850; Study Subject; Group
T39	Neg_cue 1187 1189	no
T40	LIVB 89 109	TRABAJADORES DEL SNS
#26	AnnotatorNotes T40	C1704312; Health professional; Professional or Occupational Group
T26	LIVB 380 400	Trabajadores del SNS
#27	AnnotatorNotes T26	C1704312; Health professional; Professional or Occupational Group
T41	LIVB 412 438	estudiantes universitarios
#28	AnnotatorNotes T41	C0682177; College student; Population Group
A4	Assertion T23 Negated
A5	Assertion T24 Negated
A1	Status T13 History_of
A2	Status T11 History_of
T28	Observation 130 143	RESPONDEDORES
A3	Assertion T28 Negated
#29	AnnotatorNotes T28	C0919876; Therapy responder; Finding
T29	Neg_cue 127 129	NO
T30	Neg_cue 287 289	no
T34	Observation 290 303	respondedores
A6	Assertion T34 Negated
#30	AnnotatorNotes T34	C0919876; Therapy responder; Finding
T35	Observation 566 579	respondedores
#31	AnnotatorNotes T35	C0919876; Therapy responder; Finding
A7	Assertion T35 Negated
T42	Neg_cue 563 565	NO
R1	Negation Arg1:T42 Arg2:T35	
T43	Quantifier_or_Qualifier 56 64	ADYUVADA
R2	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T43	
R4	Experiences Arg1:T40 Arg2:T1	
R5	Negation Arg1:T29 Arg2:T28	
R6	Before Arg1:T17 Arg2:T28	
R7	Experiences Arg1:T40 Arg2:T17	
R8	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T28	
T44	Observation 225 241	riesgo biológico
R9	Experiences Arg1:T27 Arg2:T44	
R10	Experiences Arg1:T27 Arg2:T4	
A8	Status T4 History_of
R11	Before Arg1:T4 Arg2:T34	
R12	Negation Arg1:T30 Arg2:T34	
R13	Experiences Arg1:T27 Arg2:T34	
R14	Before Arg1:T5 Arg2:T34	
A9	Status T5 History_of
R15	Experiences Arg1:T27 Arg2:T5	
R3	Experiences Arg1:T40 Arg2:T2	
R16	Experiences Arg1:T27 Arg2:T6	
R17	Before Arg1:T19 Arg2:T35	
#32	AnnotatorNotes T3	C0201478; Hepatitis B surface antibody measurement; Laboratory Procedure
#33	AnnotatorNotes T20	C0369334; Hepatitis B Virus Surface Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor
T45	Result_or_Value 645 656	< 10 mUI/ml
R18	Has_Result_or_Value Arg1:T3 Arg2:T45	
R19	After Arg1:T3 Arg2:T9	
R20	Used_for Arg1:T21 Arg2:T9	
R21	Has_Dose_or_Strength Arg1:T21 Arg2:T31	
R22	Has_Dose_or_Strength Arg1:T21 Arg2:T32	
T46	Quantifier_or_Qualifier 731 734	dos
R24	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T46	
#34	AnnotatorNotes T46	C0205448; Two; Quantitative Concept
T47	Quantifier_or_Qualifier 742 751	completas
#35	AnnotatorNotes T47	C0205197; Complete; Qualitative Concept
R25	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T47	
R26	After Arg1:T3 Arg2:T10	
R27	Causes Arg1:T18 Arg2:T11	
R28	Causes Arg1:T12 Arg2:T11	
R29	Causes Arg1:T22 Arg2:T13	
#36	AnnotatorNotes T22	C2240392; Hepatitis B Vaccines; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
R30	Causes Arg1:T15 Arg2:T16	
T48	Quantifier_or_Qualifier 1093 1098	grave
#37	AnnotatorNotes T48	C1547227; Severe -Severity of Illness Code; Intellectual Product
R31	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T48	
R32	Negation Arg1:T37 Arg2:T23	
R33	Negation Arg1:T39 Arg2:T24	
R23	Used_for Arg1:T21 Arg2:T10	
R34	Used_for Arg1:T19 Arg2:T10	
#38	AnnotatorNotes T44	C1948091; biological hazards; Finding
#39	AnnotatorNotes T43	C1522673; Adjuvant; Functional Concept (?)
A10	Assertion T15 Hypothetical
A11	Assertion T48 Hypothetical
A12	Assertion T16 Hypothetical
A13	Experiencer T36 Patient
A14	Experiencer T38 Patient
A15	Experiencer T40 Patient
A16	Experiencer T27 Patient
A17	Experiencer T26 Patient
A18	Experiencer T41 Patient
A19	Experiencer T33 Patient
